|
|
|
You can get e-magazine links on WhatsApp. Click here
|
|
|
|
|
|
dsm-firmenich completes $10m upgrade on US site
|
|
Saturday, 11 April, 2026, 08 : 00 AM [IST]
|
|
New York, USA
|
dsm-firmenich has announced the completion of a planned $10 million modernisation program on its Schenectady premix facility in United States, transforming the site into a flagship premix hub for the Americas. Engineered to set new benchmarks in quality standards, operational performance, and sustainability across human food, dietary supplements, and infant formula premix blends, the upgraded Schenectady facility gives customers greater confidence in an increasingly demanding regulatory and commercial environment.
Schenectady now stands among the most advanced human health premix sites in North America, after being enhanced with optimised GMP zoning, improved material flow, and expanded material conditioning capabilities via cutting-edge advanced powder technologies. The reinvention was designed with customers firmly in mind: strengthening quality assurance, improving operational efficiency, and raising audit readiness, while reducing risk and enabling faster, more reliable commercialisation and well into the future.
Maximilian Fattinger, VP premix at dsm-firmenich, said, “This investment goes well beyond incremental upgrades or technical improvements—it reflects our commitment to delivering real value for our customers. By taking a generational step forward in premix excellence, we are raising the bar for quality, safety, and reliability, so customers can count on consistent performance and dependable supply. Established in 1995, the Schenectady site now enters its next chapter as a future-ready facility built to support higher service levels and long-term partnership. It underscores our belief that trust in premix solutions is earned by investing ahead of customer needs and setting uncompromising standards.”
|
|
|
|
|
|
|
|
|
|